BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLD
1926
DELISTED
TopBuild
BLD
| $696K | ﹤0.01% |
7,217
+2,252
| +45% | +$199K |
|
1927
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$140M
| $693K | ﹤0.01% |
+5
| New | +$7.96K |
|
1928
Empire State Realty Trust
ESRT
$824M
| $689K | ﹤0.01% |
48,303
+39,305
| +437% | +$555K |
|
1929
Penumbra
PEN
$12.9B
| $689K | ﹤0.01% |
5,125
+3,456
| +207% | +$535K |
|
1930
Ingevity
NGVT
$2.61B
| $688K | ﹤0.01% |
8,110
+3,236
| +66% | +$288K |
|
1931
Viasat
VSAT
$11.4B
| $685K | ﹤0.01% |
9,089
+3,233
| +55% | +$258K |
|
1932
Littelfuse
LFUS
$11.6B
| $683K | ﹤0.01% |
3,850
+3,392
| +741% | +$574K |
|
1933
Kennametal
KMT
$2.38B
| $682K | ﹤0.01% |
22,195
+6,032
| +37% | +$192K |
|
1934
STAG Industrial
STAG
$7.1B
| $681K | ﹤0.01% |
23,110
+3,244
| +16% | +$96.3K |
|
1935
Ryder
R
$10.1B
| $680K | ﹤0.01% |
13,135
-50,576
| -79% | -$2.64M |
|
1936
Integra LifeSciences
IART
$1.42B
| $673K | ﹤0.01% |
11,198
+9,877
| +748% | +$588K |
|
|
SAVE
1937
DELISTED
Spirit Airlines, Inc.
SAVE
| $670K | ﹤0.01% |
18,445
+654
| +4% | +$27.5K |
|
|
MDCO
1938
DELISTED
Medicines Co
MDCO
| $669K | ﹤0.01% |
13,386
+2,511
| +23% | +$100K |
|
|
PDCO
1939
DELISTED
Patterson Companies, Inc.
PDCO
| $668K | ﹤0.01% |
37,485
-40,804
| -52% | -$762K |
|
|
VRE
1940
DELISTED
Veris Residential
VRE
| $668K | ﹤0.01% |
30,839
+18,959
| +160% | +$421K |
|
1941
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $664K | ﹤0.01% |
44,137
+609
| +1% | +$9.31K |
|
1942
Exponent
EXPO
$3.19B
| $661K | ﹤0.01% |
9,463
+1,735
| +22% | +$117K |
|
|
BPMC
1943
DELISTED
Blueprint Medicines
BPMC
| $660K | ﹤0.01% |
8,984
+2,828
| +46% | +$244K |
|
1944
Texas Roadhouse
TXRH
$13.6B
| $656K | ﹤0.01% |
12,494
+4,891
| +64% | +$260K |
|
|
SYNH
1945
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $654K | ﹤0.01% |
12,286
+5,766
| +88% | +$296K |
|
1946
Ovintiv
OVV
$17.5B
| $653K | ﹤0.01% |
28,408
-7,928
| -22% | -$182K |
|
1947
Kirby Corp
KEX
$7.28B
| $653K | ﹤0.01% |
+7,945
| New | +$609K |
|
1948
Vermilion Energy
VET
$1.75B
| $651K | ﹤0.01% |
38,985
+12,783
| +49% | +$222K |
|
1949
CALL
Gen Digital
GEN
$17.3B
| $650K | ﹤0.01% |
275
| – | – |
|
1950
Eagle Materials
EXP
$6.38B
| $650K | ﹤0.01% |
7,217
+6,673
| +1,227% | +$573K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.